Skip to main content
MedPathMedPath Home
Clinical Trials/ACTRN12616000801415
ACTRN12616000801415
Completed
Phase 2

se of multiparametric Magnetic Resonance Imaging (MRI) and Positron Emission Tomography - Computed Tomography (PET-CT) to evaluate radiological changes after lung Stereotactic Ablative Radiotherapy (SABR) in patients with stage I/II non-small cell lung cancer (NSCLC) or lung oligometastases

iverpool Hospital0 sites23 target enrollmentJune 20, 2016
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditionson small cell lung cancer (NSCLC)Oligometastatic disease involving lungNon small cell lung cancer (NSCLC)Cancer - Lung - Non small cellCancer - Other cancer types

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
on small cell lung cancer (NSCLC)
Sponsor
iverpool Hospital
Enrollment
23
Status
Completed
Last Updated
2 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
June 20, 2016
End Date
September 10, 2023
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
iverpool Hospital

Eligibility Criteria

Inclusion Criteria

  • •Patients undergoing SABR for Stage I/II NSCLC or lung oligometastases
  • •Able to attend follow up for 2 years
  • •Over 18 years of age

Exclusion Criteria

  • •Prognosis less than 2 years
  • •Patient refusal
  • •Contraindication to MRI
  • •Inability to give informed consent

Outcomes

Primary Outcomes

Not specified

Similar Trials

Recruiting
Not Applicable
Multi-parametric MRI for Therapeutic Response Prediction in Rectal CancerRectal CancerCancer - Bowel - Back passage (rectum) or large bowel (colon)
ACTRN12616001690448Dr Trang Pham35
Recruiting
Not Applicable
Multiparametric magnetic resonance imaging for evaluation of diffuse and focal liver diseaseK76.9Liver disease, unspecified
DRKS00007859niversitätsklinikum Bonn1,000
Recruiting
Not Applicable
Evaluate - can magnetic resonance imaging (MRI) pick up early tumour spread in pancreatic cancer?
ISRCTN15395684niversity Hospitals Bristol NHS Foundation Trust30
Recruiting
Phase 3
Evaluation of Multiparametric Magnetic Resonance Imaging and Positron Emission Tomography with a [68Ga]gallium-labelled prostate-specific membrane antigen (PSMA) ligand for the Detection of Multiple Cancer Foci in Localized Prostate Cancer Patients – A Pilot Studyocalized Prostate CancerLocalized Prostate CancerCancer - Prostate
ACTRN12614000783628Queensland University of Technology20
Completed
Not Applicable
MRI in Active Surveillance of Prostate CancerProstate Cancer
NCT02326246Aarhus University Hospital Skejby85